Delivery Order SPE2DB24D2109-SPE2DB25FHXTP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,258.62 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $49,377.86 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $6,133.96 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count packages), with an ultimate completion date of August 14, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) vehicle—specifically the DLA Troop Support Medical SPE2DX prime vendor contract valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $17,176.10 delivery order from the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count). This firm fixed-price, competitively awarded contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- The Defense Logistics Agency awarded a $22,683.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of July 30, 2025. This non-set-aside award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical supply vehicle for military and federal healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $34,348.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 20, 2025, with completion expected by August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a $50,623.08 delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, a widely used anticoagulant medication. The contract was competitively awarded with no set-aside designation under a firm fixed-price structure, with an ultimate completion date of August 18, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this delivery order. This award represents a task...
- The U.S. Defense Logistics Agency (DLA) awarded a $132,002.22 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 4,565,427,049 units of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
- The Defense Logistics Agency awarded a delivery order valued at $33,106.50 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of July 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXTPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $99,073.02 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of August 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This delivery order falls under AmerisourceBergen's comprehensive pharmaceutical supply agreement that enables the company to distribute a broad portfolio of medications, medical devices, and healthcare commodities to support military healthcare operations globally. Eliquis, an anticoagulant medication used for stroke prevention and blood clot treatment, exemplifies the brand-name pharmaceutical products the company supplies through its DLA contract vehicle. AmerisourceBergen's federal contract portfolio demonstrates its capability to fulfill the Defense Logistics Agency's medical supply requirements through open competition, serving customers including the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $99.1k | 8/20/25 |